mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.008 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.009 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.01 |